Corvus Pharmaceuticals, Inc. (CRVS)
15.11
-0.14
(-0.92%)
USD |
NASDAQ |
Apr 15, 16:00
14.61
-0.50
(-3.31%)
After-Hours: 04:09
Corvus Pharmaceuticals Research and Development Expense (Annual) : 33.72M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 5.306B |
| Plus Therapeutics, Inc. | 8.379M |
| Geron Corp. | 71.43M |
| Nektar Therapeutics | 117.07M |
| Jaguar Health, Inc. | 24.97M |